Mereo Biopharma Group Plc ADR (MREO)

$4.38 +0.03 (0.69%)
Market Cap 530.17M
Revenue (ttm) 10.00M
Net Income (ttm) -29.47M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 28,075
Avg Vol 812,584
Day's Range N/A - N/A
Shares Out 140.26M
Stochastic %K 30%
Beta 0.88
Analysts Strong Sell
Price Target $6.80

Company Profile

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of rare diseases in the United Kingdom and the United States. The company develops Setrusumab, an antibody for the treatment of osteogenesis imperfecta; Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency associated lung disease; and Vantictumab, an anti-FZD monoclonal antibody for the treatment of autosomal dominant osteope...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 33 3023 7300
Address:
One Cavendish Place, 4th Floor, London, United Kingdom
OutperformGER
OutperformGER Jul. 25 at 3:47 PM
$MREO and $RARE Emil Kakkis 👇
0 · Reply
LDT79
LDT79 Jul. 24 at 2:50 PM
$MREO fuck off Denise
0 · Reply
Teamtalk2014
Teamtalk2014 Jul. 24 at 10:33 AM
$MREO
1 · Reply
Mhjh
Mhjh Jul. 23 at 2:41 PM
$MREO MREO | Mereo BioPharma Group Jul 22 Consensus revenue estimates increase by 593% The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast increased from US$1.17M to US$8.12M. EPS estimate unchanged from -US$0.038 at last update. Biotechs industry in the US expected to see average net income decline 12% next year. Consensus price target of US$1.75 unchanged from last update. Share price fell 9.2% to US$0.30 over the past week. Source: https://simplywall.st/
0 · Reply
GamblingFerret
GamblingFerret Jul. 22 at 5:43 PM
$MREO time to regain compliance until August 17. Alvelestat deal is incoming within next 2 weeks, make sure you are on board!
1 · Reply
theSmokingBuzzard
theSmokingBuzzard Jul. 22 at 5:23 PM
$MREO Worst stock of all time
0 · Reply
Spiceman63
Spiceman63 Jul. 22 at 5:08 PM
$MREO Back in for 10,000 shares at $.30. I sold a couple years ago when it made its move to $4 and made a ton. Still shocked Denise is the CEO and Lewicki is still with the company. I would dump those guys.
1 · Reply
LDT79
LDT79 Jul. 22 at 4:15 PM
$MREO come on Denise - do something good Lord!!!
0 · Reply
ClenchFists
ClenchFists Jul. 20 at 7:30 PM
$MREO Buying cheap!!! Let's gooo
1 · Reply
Crivit
Crivit Jul. 20 at 9:16 AM
$MREO https://x.com/ej23ny/status/2078847523209327096?s=46&t=bEBIliluVsTI7poV3L9h2Q
0 · Reply
Latest News on MREO
4basebio Announces Appointment of Chief Financial Officer and Board Changes

Thu, 14 May 2026 07:00:00 -0400 - 2 months ago

4basebio Announces Appointment of Chief Financial Officer and Board Changes

Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Tue, 12 May 2026 07:30:00 -0400 - 2 months ago

Mereo BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join – Contact Levi & Korsinsky

Mon, 06 Apr 2026 16:00:00 -0400 - 4 months ago

Class Action Filed Against Mereo BioPharma Group plc (MREO) - April 6, 2026 Deadline to Join – Contact Levi & Korsinsky

MREO DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

Mon, 06 Apr 2026 15:18:00 -0400 - 4 months ago

MREO DEADLINE TODAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

MREO DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Mon, 06 Apr 2026 13:05:00 -0400 - 4 months ago

MREO DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MEREO LAWSUIT DEADLINE TODAY: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Regarding Their Rights

Mon, 06 Apr 2026 10:48:00 -0400 - 4 months ago

MEREO LAWSUIT DEADLINE TODAY: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Regarding Their Rights

MREO FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Mon, 06 Apr 2026 09:18:00 -0400 - 4 months ago

MREO FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

Mon, 06 Apr 2026 03:45:00 -0400 - 4 months ago

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Mon, 06 Apr 2026 02:32:00 -0400 - 4 months ago

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

Sun, 05 Apr 2026 16:59:00 -0400 - 4 months ago

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

MREO DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Sun, 05 Apr 2026 13:00:00 -0400 - 4 months ago

MREO DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Sun, 05 Apr 2026 08:18:00 -0400 - 4 months ago

MREO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

MREO DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Sat, 04 Apr 2026 10:59:00 -0400 - 4 months ago

MREO DEADLINE ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor Harm

Fri, 03 Apr 2026 12:00:00 -0400 - 4 months ago

Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor Harm

MREO FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

Fri, 03 Apr 2026 11:41:00 -0400 - 4 months ago

MREO FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

MREO Deadline: Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

Fri, 03 Apr 2026 11:33:00 -0400 - 4 months ago

MREO Deadline: Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026

Fri, 03 Apr 2026 09:08:00 -0400 - 4 months ago

MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026

DEADLINE APPROACHING: Berger Montague Advises BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

Thu, 02 Apr 2026 12:21:00 -0400 - 4 months ago

DEADLINE APPROACHING: Berger Montague Advises BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Thu, 02 Apr 2026 10:17:00 -0400 - 4 months ago

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO

Thu, 02 Apr 2026 10:00:00 -0400 - 4 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO

MREO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Wed, 01 Apr 2026 18:30:00 -0400 - 4 months ago

MREO DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Mereo BioPharma Group plc (MREO) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

Wed, 01 Apr 2026 12:26:00 -0400 - 4 months ago

Mereo BioPharma Group plc (MREO) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Wed, 01 Apr 2026 09:50:00 -0400 - 4 months ago

MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Shareholders that lost money on Mereo BioPharma Group plc(MREO) should contact Levi & Korsinsky about pending Class Action - MREO

Wed, 01 Apr 2026 09:00:00 -0400 - 4 months ago

Shareholders that lost money on Mereo BioPharma Group plc(MREO) should contact Levi & Korsinsky about pending Class Action - MREO

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

Tue, 31 Mar 2026 18:37:00 -0400 - 4 months ago

MREO Deadline: MREO Investors with Losses in Excess of $100K Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

MREO DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

Tue, 31 Mar 2026 17:01:00 -0400 - 4 months ago

MREO DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO

Tue, 31 Mar 2026 15:50:00 -0400 - 4 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO

MEREO BIOPHARMA GROUP PLC (MREO) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

Tue, 31 Mar 2026 12:21:00 -0400 - 4 months ago

MEREO BIOPHARMA GROUP PLC (MREO) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

MREO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Mereo BioPharma Group plc Securities Lawsuit -- The Gross Law Firm

Tue, 31 Mar 2026 09:00:00 -0400 - 4 months ago

MREO Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Mereo BioPharma Group plc Securities Lawsuit -- The Gross Law Firm

MREO FINAL DEADLINE: ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Mon, 30 Mar 2026 22:58:00 -0400 - 4 months ago

MREO FINAL DEADLINE: ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Mon, 30 Mar 2026 18:51:00 -0400 - 4 months ago

MREO EQUITY ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Mon, 30 Mar 2026 10:00:00 -0400 - 4 months ago

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Mon, 30 Mar 2026 03:43:00 -0400 - 4 months ago

MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

Mon, 30 Mar 2026 03:42:00 -0400 - 4 months ago

Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO

MREO FINAL DEADLINE: ROSEN, LONGSTANDING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Sun, 29 Mar 2026 22:51:00 -0400 - 4 months ago

MREO FINAL DEADLINE: ROSEN, LONGSTANDING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO FINAL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Sat, 28 Mar 2026 22:23:00 -0400 - 4 months ago

MREO FINAL DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Sat, 28 Mar 2026 10:03:00 -0400 - 4 months ago

MREO UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

MREO FINAL DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Fri, 27 Mar 2026 16:05:00 -0400 - 4 months ago

MREO FINAL DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Mereo BioPharma Group plc Investors with Losses in Excess of $100K to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor Harm

Fri, 27 Mar 2026 12:00:00 -0400 - 4 months ago

Bronstein, Gewirtz & Grossman LLC Urges Mereo BioPharma Group plc Investors to Act: Class Action Filed Alleging Investor Harm

MREO Shareholder Alert: Mereo BioPharma Group plc Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm

Fri, 27 Mar 2026 11:03:00 -0400 - 4 months ago

MREO Shareholder Alert: Mereo BioPharma Group plc Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm

MREO INVESTOR ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

Fri, 27 Mar 2026 09:31:00 -0400 - 4 months ago

MREO INVESTOR ALERT: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO

Thu, 26 Mar 2026 10:00:00 -0400 - 4 months ago

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines - MREO

INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

Thu, 26 Mar 2026 08:55:00 -0400 - 4 months ago

INVESTOR ALERT: Berger Montague Advises Mereo BioPharma Group PLC (NASDAQ: MREO) Investors to Inquire About a Securities Fraud Class Action by April 6, 2026

MREO Deadline: MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

Wed, 25 Mar 2026 22:52:00 -0400 - 4 months ago

MREO Deadline: MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit

MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

Wed, 25 Mar 2026 18:16:00 -0400 - 4 months ago

MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action – MREO

MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

Wed, 25 Mar 2026 18:08:00 -0400 - 4 months ago

MREO FINAL DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important April 6 Deadline in Securities Class Action - MREO

MREO Investor Alert - Mereo BioPharma Group plc Investors with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

Wed, 25 Mar 2026 17:06:00 -0400 - 4 months ago

MREO Investor Alert - Mereo BioPharma Group plc Investors with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

MEREO LAWSUIT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Before April 6th

Wed, 25 Mar 2026 16:04:00 -0400 - 4 months ago

MEREO LAWSUIT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Mereo BioPharma Stockholders with Large Losses to Contact the Firm Before April 6th

MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026

Wed, 25 Mar 2026 12:22:00 -0400 - 4 months ago

MREO INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Mereo BioPharma Investors of Securities Class Action Deadline on April 6, 2026

Shareholders of Mereo BioPharma Group plc Should Contact Levi & Korsinsky Before April 6, 2026 to Discuss Your Rights - MREO

Wed, 25 Mar 2026 09:00:00 -0400 - 4 months ago

Shareholders of Mereo BioPharma Group plc Should Contact Levi & Korsinsky Before April 6, 2026 to Discuss Your Rights - MREO

Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims

2026-03-24T11:16:17.000Z - 4 months ago

Shareholders Sue Mereo BioPharma (MREO) Over Brittle Bone Drug Claims

NVS RARE

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

2026-03-23T09:10:08.000Z - 4 months ago

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

2026-03-20T20:50:18.000Z - 4 months ago

Mereo BioPharma downgraded to Neutral from Overweight at JPMorgan

Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights

Mar 19, 2026, 8:30 AM EDT - 4 months ago

Mereo BioPharma Reports Full Year 2025 Financial Results and Provides Corporate Highlights

Stockholders Who Lost Money Investing in Mereo BioPharma Group plc Should Contact Robbins LLP for Information About Recovering Their Losses from MREO

Feb 18, 2026, 2:11 PM EST - 5 months ago

Stockholders Who Lost Money Investing in Mereo BioPharma Group plc Should Contact Robbins LLP for Information About Recovering Their Losses from MREO

Mereo BioPharma sees cash runway into mid-2027

2026-01-12T13:20:17.000Z - 7 months ago

Mereo BioPharma sees cash runway into mid-2027

Mereo BioPharma downgraded to Hold from Buy at Jefferies

2025-12-30T01:50:19.000Z - 7 months ago

Mereo BioPharma downgraded to Hold from Buy at Jefferies

RARE

Mereo BioPharma price target lowered to $1, ‘Fresh Pick’ removed at Baird

2025-12-29T18:50:09.000Z - 7 months ago

Mereo BioPharma price target lowered to $1, ‘Fresh Pick’ removed at Baird

Mereo BioPharma price target lowered to $1 from $6 at BTIG

2025-12-29T18:40:08.000Z - 7 months ago

Mereo BioPharma price target lowered to $1 from $6 at BTIG

Mereo BioPharma downgraded to Market Perform from Outperform at LifeSci Capital

2025-12-29T18:10:09.000Z - 7 months ago

Mereo BioPharma downgraded to Market Perform from Outperform at LifeSci Capital

These biotech stocks are getting hammered by shocking brittle-bone treatment study results

Dec 29, 2025, 1:05 PM EST - 7 months ago

These biotech stocks are getting hammered by shocking brittle-bone treatment study results

RARE

Mereo BioPharma price target lowered to $3 from $6 at Cantor Fitzgerald

2025-12-29T17:10:17.000Z - 7 months ago

Mereo BioPharma price target lowered to $3 from $6 at Cantor Fitzgerald

Mereo Biopharma Stock (MREO) Collapses over 90% after Failed Trials

2025-12-29T16:34:28.000Z - 7 months ago

Mereo Biopharma Stock (MREO) Collapses over 90% after Failed Trials

AZN INSM RCUS

Mereo BioPharma Group trading resumes

2025-12-29T13:55:07.000Z - 7 months ago

Mereo BioPharma Group trading resumes

Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab (UX143) in Osteogenesis Imperfecta

Dec 29, 2025, 8:31 AM EST - 7 months ago

Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab (UX143) in Osteogenesis Imperfecta

āshibio Expands Clinical Pipeline with Vantictumab, a First-In-Class Antibody for Autosomal Dominant Osteopetrosis Type 2

Aug 19, 2025, 8:30 AM EDT - 1 year ago

āshibio Expands Clinical Pipeline with Vantictumab, a First-In-Class Antibody for Autosomal Dominant Osteopetrosis Type 2

Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights

Aug 12, 2025, 7:35 AM EDT - 1 year ago

Mereo BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Highlights

Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights

May 13, 2025, 7:30 AM EDT - 1 year ago

Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights

Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights

Mar 26, 2025, 7:30 AM EDT - 1 year ago

Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference

Mar 5, 2025, 7:30 AM EST - 1 year ago

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference

Mereo BioPharma Provides Update on Lead Clinical Programs

Jan 12, 2025, 11:05 AM EST - 1 year ago

Mereo BioPharma Provides Update on Lead Clinical Programs

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 7, 2025, 7:30 AM EST - 1 year ago

Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

Nov 14, 2024, 7:30 AM EST - 1 year ago

Mereo BioPharma to Participate in Fireside Chat at the Jefferies London Healthcare Conference

Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12, 2024, 7:30 AM EST - 1 year ago

Mereo BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

Sep 12, 2024, 5:35 PM EDT - 2 years ago

Mereo BioPharma to Participate in Fireside Chat at the 2024 Cantor Global Healthcare Conference

Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 13, 2024, 8:00 AM EDT - 2 years ago

Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market

Jun 14, 2024, 7:50 AM EDT - 2 years ago

Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market

Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

May 30, 2024, 7:30 AM EDT - 2 years ago

Mereo BioPharma to Participate in Fireside Chat at the Jefferies Global Healthcare Conference

Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

May 15, 2024, 4:01 PM EDT - 2 years ago

Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Apr 3, 2024, 7:30 AM EDT - 2 years ago

Mereo BioPharma to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update

Mar 27, 2024, 4:01 PM EDT - 2 years ago

Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference

Mar 5, 2024, 7:30 AM EST - 2 years ago

Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Biopharma Conference

Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments

Jan 8, 2024, 7:00 AM EST - 2 years ago

Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments

Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update

Oct 23, 2023, 4:01 PM EDT - 3 years ago

Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update

Mereo BioPharma to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference

Sep 21, 2023, 7:00 AM EDT - 3 years ago

Mereo BioPharma to Participate in Fireside Chat at the 2023 Cantor Global Healthcare Conference

Mereo BioPharma Reports Interim Financial Results for the Six Months Ended June 30, 2023 and Provides Corporate Update

Sep 7, 2023, 7:30 AM EDT - 3 years ago

Mereo BioPharma Reports Interim Financial Results for the Six Months Ended June 30, 2023 and Provides Corporate Update

OutperformGER
OutperformGER Jul. 25 at 3:47 PM
$MREO and $RARE Emil Kakkis 👇
0 · Reply
LDT79
LDT79 Jul. 24 at 2:50 PM
$MREO fuck off Denise
0 · Reply
Teamtalk2014
Teamtalk2014 Jul. 24 at 10:33 AM
$MREO
1 · Reply
Mhjh
Mhjh Jul. 23 at 2:41 PM
$MREO MREO | Mereo BioPharma Group Jul 22 Consensus revenue estimates increase by 593% The consensus outlook for fiscal year 2026 has been updated. 2026 revenue forecast increased from US$1.17M to US$8.12M. EPS estimate unchanged from -US$0.038 at last update. Biotechs industry in the US expected to see average net income decline 12% next year. Consensus price target of US$1.75 unchanged from last update. Share price fell 9.2% to US$0.30 over the past week. Source: https://simplywall.st/
0 · Reply
GamblingFerret
GamblingFerret Jul. 22 at 5:43 PM
$MREO time to regain compliance until August 17. Alvelestat deal is incoming within next 2 weeks, make sure you are on board!
1 · Reply
theSmokingBuzzard
theSmokingBuzzard Jul. 22 at 5:23 PM
$MREO Worst stock of all time
0 · Reply
Spiceman63
Spiceman63 Jul. 22 at 5:08 PM
$MREO Back in for 10,000 shares at $.30. I sold a couple years ago when it made its move to $4 and made a ton. Still shocked Denise is the CEO and Lewicki is still with the company. I would dump those guys.
1 · Reply
LDT79
LDT79 Jul. 22 at 4:15 PM
$MREO come on Denise - do something good Lord!!!
0 · Reply
ClenchFists
ClenchFists Jul. 20 at 7:30 PM
$MREO Buying cheap!!! Let's gooo
1 · Reply
Crivit
Crivit Jul. 20 at 9:16 AM
$MREO https://x.com/ej23ny/status/2078847523209327096?s=46&t=bEBIliluVsTI7poV3L9h2Q
0 · Reply
Crivit
Crivit Jul. 20 at 9:16 AM
$MREO https://x.com/heatlamp11/status/2077789640874930571?s=46&t=bEBIliluVsTI7poV3L9h2Q
0 · Reply
GamblingFerret
GamblingFerret Jul. 17 at 10:04 AM
$MREO The biggest Blackbox for me is Navicixizumab, as this is outlicensed to Feng Biosciences, a private company with VC backing sharing 0 information. Competitor Compass has a similar asset (Tovecimig), which scored strong Phase 3 data lately and is in phase 2 ovarian cancer as well —> The asset class is working. Could be an unplanned upside
1 · Reply
GamblingFerret
GamblingFerret Jul. 16 at 1:52 PM
$MREO Stay patient… Stock moves sideway since 1 1/2 month, but lower end is increasing while volumes decline, overall but especially in negative moves. Alvelestat deal is close given the communicated timeline by Mereo. On top, agency feedback on Setrusumab is pending and should be available latest end of august. Next month will be nice, and additional newsflow from other pipeline Assets is possible anytime (but hard to predict). Vantictumab, Leflutrozole, Navicixizumab, Etigilimab, Acumapimod
2 · Reply
Crivit
Crivit Jul. 15 at 11:26 AM
$MREO
0 · Reply
LDT79
LDT79 Jul. 14 at 3:05 PM
$MREO scared CEO will not deliver anything - our only hope is Emil Kakkis from $RARE
0 · Reply
theSmokingBuzzard
theSmokingBuzzard Jul. 14 at 2:05 PM
$MREO
1 · Reply
Rojingeorge
Rojingeorge Jul. 10 at 8:00 PM
$MREO Coiled Spring Set-Up .
1 · Reply
GamblingFerret
GamblingFerret Jul. 10 at 3:55 PM
$MREO Fresh Etigilimab data by M. D. Anderson, showing improved efficacy (15% response rate) and managable safety profile (0 DLT) of etigilimab in Platinum-resistant, Recurrent Epithelial Ovarian Cancer in combination with Nivo. It is not practice changing, but opens door to potential partnering as it shows TIGIT is working in this selected indication. Interesting as well: clinical benefit in 30% of patients, median duration of response 8.6 months. https://clinicaltrials.gov/study/NCT05715216?term=Mereo%20biopharma&viewType=Card&aggFilters=status:not%20rec%20act&rank=1&tab=results&a=14&b=15 Mereo states the asset as partnering ready, These data should create new oppertunities. If succesfull, the value of etigilimab alone is multiple times higher than current company valuation in total.
1 · Reply
theSmokingBuzzard
theSmokingBuzzard Jul. 9 at 4:54 PM
$MREO How much stonk could a wood chunk consolidate if a wood chunk could consolidate stonk?
0 · Reply
theSmokingBuzzard
theSmokingBuzzard Jul. 7 at 7:40 PM
$MREO Okay, let her rip please !
0 · Reply
Spiceman63
Spiceman63 Jul. 7 at 7:03 PM
$MREO MREO has fallen 94% under Denise. It amazes me how these CEO’s keep their jobs.
0 · Reply
LDT79
LDT79 Jul. 7 at 1:08 PM
$MREO please please please please give us the news we need: Denise gone 😫
1 · Reply